Subcutaneous administration provides the appropriate absorption rate for this peptide
Learn more about our Obesity Clinic and how GLP-1s can help patients See why you should partner with a primary care provider for your health This blog was medically reviewed by endocrinologist Miranda Stiewig-Rapp.
GLP-1 (Glucagon-Like Peptide-1) is primarily produced in enteroendocrine L-cells located in the distal small intestine (ileum) and colon in response to eating
Where appropriate, a replacement shipment may be arranged
We focus on building sustainable habits around protein intake, hydration, fiber, and exercise that will serve you long after you reach your goal
Results showed that BN could reduce glucose levels, improve insulin secretion in glucose tolerance tests in a dose-dependent manner, and inhibit food intake and gastric emptying